• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream

    8/20/25 7:00:00 AM ET
    $ADVM
    $CLNN
    $DERM
    $EHGO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADVM alert in real time by email

    MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 85th Emerging Growth Conference on August 20 & 21, 2025.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1 – Presenting Today, August 20, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Immuron Limited (NASDAQ:IMRN)

    Keynote speaker: Steve Lydeamore, CEO

    9:40 – 10:10

    Nutriband, Inc. (NASDAQ:NTRB)

    Keynote speaker: Serguei Melnik, Founder and President

    10:50 – 11:20

    Metaguest.ai Inc. (OTCQB:MGSTF) (CSE:METG)

    Keynote speaker: Colin Keddy, President

    11:25 – 11:55

    Kelly+Partners (OTCQX:KPGHF) (ASX: KPG)

    Keynote speaker: Brett Kelly, Founder, Executive Chairman & CEO

    12:35 – 1:05

    Journey Medical Corporation (NASDAQ:DERM)

    Keynote speaker: Claude Maraoui - Founder, President, CEO & Director

    1:10 – 1:40

    22nd Century Group, Inc. (NASDAQ:XXII)

    Keynote speaker: Lawrence D. Firestone, Chairman & CEO

    1:45 – 2:15

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

    2:20 – 2:50

    Clene Inc., (NASDAQ:CLNN)

    Keynote speakers: Rob Etherington, President / CEO

    2:55 – 3:05

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    3:10 – 3:20

    HeartSciences, Inc. (NASDAQ:HSCS)

    Keynote speaker: Andrew Simpson, President / CEO

    Postponed to September 24

    Adverum Biotechnologies (NASDAQ:ADVM)

    Keynote speaker: Jason Awe, PhD, MBA, Corporate Communications & IR

    3:40 – 3:50

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speakers: David Dodd, Chairman, President / CEO

    3:55 – 4:05

    BitFuFu Inc. (NASDAQ:FUFU)

    Keynote speaker: Charley Brady, VP Investor Relations

    4:10 – 4:20

    Impact Minerals Limited, (ASX: IPT)

    Keynote speaker: Dr. Mike Jones, Managing Director

    4:25 – 4:35

    Zyppah, a Private Company

    Keynote speaker: Dr. Jonathan Greenburg, founder and owner, & Larry Biggs, CEO

    4:40 – 4:50

    Ucore Rare Metals, Inc. (OTCQX:UURAF) (TSXV:UCU)

    Keynote speakers: Pat Ryan, CEO

    _______________________________________________________________

    Day 2 – Presenting Tomorrow, August 21, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Eshallgo, Inc. (NASDAQ:EHGO)

    Keynote speakers: Johnny Wu, President

    10:15 – 10:45

    Terra Clean Energy (OTCQB:TCEFF) (CSE:TCEC)

    Keynote speaker: Greg Cameron, CEO

    10:50 – 11:20

    Grove Collaborative Holdings, Inc. (NYSE:GROV)

    Keynote speakers: Jeff Yurcisin, CEO & Tom Siragusa, Interim CFO

    11:25 – 11:55

    Phoenix Energy Services Corp., (OTCQB:PHXHF) (TSE: PHX)

    Keynote speaker: Mike Buker, President and CEO

    12:00 – 12:30

    Vista Gold Corp. (NYSE:VGZ) (TSX:VGZ)

    Keynote speaker: Frederick Earnest, CEO

    12:35 – 1:05

    Eloro Resources, Ltd. (OTCQX:ELRRF) (TSX:ELO)

    Keynote speakers: Chris Holden – VP Corporate Development

    1:10 – 1:40

    Kobo Resources, Inc. (OTCQB:KBRIF) (TSXV:KRI)

    Keynote speakers: Edouard Gosselin, Director, CEO and Corporate Secretary & Paul Sarjeant, Director, President and COO

    1:45 – 2:15

    Puma Exploration Inc. (TSXV:PUMA) (OTCQB:PUMXF)

    Marcel Robillard, CEO & President

    2:20 – 2:50

    U.S. Energy Corporation (NASDAQ:USEG)

    Keynote speaker: Ryan Smith, President, CEO & Director

    2:55 – 3:05

    Highland Copper Company Inc. (OTCQB:HDRSF) (TSXV:HI)

    Keynote speaker: Barry O'Shea, CEO

    3:10 - 3:20

    Odyssey Marine Exploration, Inc. (NASDAQ:OMEX)

    Keynote speaker: Mark D. Gordon, Chairman & CEO

    3:25 – 3:35

    C3 Metals Inc. (TSXV:CCCM) (OTCQB:CUAUF)

    Keynote speaker: Daniel A. Symons, President, CEO & Director

    3:40 – 3:50

    Lahontan Gold Corp. (TSXV:LG) (OTCQB:LGCXF)

    Keynote speaker: Kimberly Ann, President / CEO

    3:55 – 4:05

    Opawica Explorations Inc. (OTCQB:OPWEF) (TSXV:OPW)

    Keynote speaker: Blake Morgan, President / CEO

    4:10 – 4:20

    Vizsla Royalties Corp. (TSXV:VROY) (OTCQB:VROYF)

    Keynote speaker: Michael N. Pettingell, President and CEO

    4:25 – 4:35

    Star Gold Corp. (OTCQB:SRGZ)

    Keynote speaker: Lindsay E. Gorrill, Chairman & CEO

    4:40 – 4:50

    NCS Multistage Holdings, Inc. (NASDAQ:NCSM)

    Keynote speaker: Ryan Hummer, CEO & Director

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $ADVM alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $CLNN
    $DERM
    $EHGO

    CompanyDatePrice TargetRatingAnalyst
    Journey Medical Corporation
    $DERM
    8/25/2025$13.00Buy
    H.C. Wainwright
    BitFuFu Inc.
    $FUFU
    8/13/2025$6.00Buy
    Roth Capital
    Journey Medical Corporation
    $DERM
    7/30/2025$12.00Buy
    B. Riley Securities
    BitFuFu Inc.
    $FUFU
    7/18/2025Buy
    B. Riley Securities
    BitFuFu Inc.
    $FUFU
    6/18/2025$5.50Market Perform
    Northland Capital
    Grove Collaborative Holdings Inc.
    $GROV
    5/15/2025$1.20Outperform → Market Perform
    Telsey Advisory Group
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$15.00 → $8.50Buy
    Alliance Global Partners
    More analyst ratings

    $ADVM
    $CLNN
    $DERM
    $EHGO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Immuron Announces Clinical Trial Update

    IMM-529 IND: currently under review, FDA request for Information – minor updates to clinical protocol completed and submitted Travelan® P2TD (n=851) Uniformed Services University study topline data delayed to the end of November due to U.S government shutdown MELBOURNE, Australia, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company provides a clinical trial update on Travelan® and IMM-529. IMM-529 IND (Clostridioides difficile infection)Immuron announced on October 8, 2025 submission of an Investigational New Drug (IND) application to the United States Food and Drug Administration (FDA) for the

    10/31/25 6:00:00 AM ET
    $IMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Grove to Report Third Quarter 2025 Financial Results on November 13, 2025

    Grove Collaborative Holdings, Inc. (NYSE:GROV) ("Grove" or "the Company"), the world's first plastic-neutral retailer and a leading sustainable consumer products company, certified B Corporation, and Public Benefit Corporation today announced that it will report third quarter 2025 financial results after the market closes on Thursday, November 13, 2025. The Company will host an investor conference call and webcast to review these financial results at 5:00pm ET / 2:00pm PT on the same day. The webcast can be accessed at https://investors.grove.co/. The conference call can be accessed by calling 877-413-7205. International callers may dial +1 201-689-8537. A replay of the call will be avail

    10/30/25 4:10:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    NCS Multistage Holdings, Inc. Announces Third Quarter 2025 Results

    Third Quarter Results Total revenues of $46.5 million, a 6% year-over-year improvementNet income of $3.8 million and diluted earnings per share of $1.37, compared to net income of $4.1 million and diluted earnings per share of $1.60 in the same quarter of 2024Adjusted EBITDA of $7.0 million, consistent with the same quarter of 2024 $25.3 million in cash and $7.4 million of total debt as of September 30, 2025 HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (NASDAQ:NCSM) (the "Company," "NCS," "we" or "us"), a leading provider of highly engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completio

    10/29/25 4:05:00 PM ET
    $NCSM
    Oilfield Services/Equipment
    Energy

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Smith Ryan Lewis bought $4,560 worth of shares (4,000 units at $1.14), increasing direct ownership by 0.34% to 1,183,039 units (SEC Form 4)

    4 - US ENERGY CORP (0000101594) (Issuer)

    9/15/25 7:00:12 AM ET
    $USEG
    Oil & Gas Production
    Energy

    CEO Smith Ryan Lewis bought $2,340 worth of shares (2,000 units at $1.17), increasing direct ownership by 0.17% to 1,179,039 units (SEC Form 4)

    4 - US ENERGY CORP (0000101594) (Issuer)

    8/14/25 7:00:13 AM ET
    $USEG
    Oil & Gas Production
    Energy

    Chief Medical Officer Mckee Kelly T. Jr. bought $742 worth of shares (1,107 units at $0.67), increasing direct ownership by 46% to 3,494 units (SEC Form 4)

    4 - GeoVax Labs, Inc. (0000832489) (Issuer)

    8/8/25 3:13:56 PM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Member of 10% owner group Weinzierl John A acquired 796,761 shares and disposed of 1,400,000 shares (SEC Form 4)

    4 - US ENERGY CORP (0000101594) (Issuer)

    10/30/25 6:16:11 PM ET
    $USEG
    Oil & Gas Production
    Energy

    Member of 10% owner group King Duane H acquired 332,329 shares and disposed of 1,400,000 shares (SEC Form 4)

    4 - US ENERGY CORP (0000101594) (Issuer)

    10/30/25 6:15:40 PM ET
    $USEG
    Oil & Gas Production
    Energy

    Member of 10% owner group Batchelor Joshua Lane sold $675,575 worth of shares (538,410 units at $1.25) (SEC Form 4)

    4 - US ENERGY CORP (0000101594) (Issuer)

    10/28/25 5:20:24 PM ET
    $USEG
    Oil & Gas Production
    Energy

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright initiated coverage on Journey Medical with a new price target

    H.C. Wainwright initiated coverage of Journey Medical with a rating of Buy and set a new price target of $13.00

    8/25/25 8:12:40 AM ET
    $DERM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Roth Capital initiated coverage on BitFuFu with a new price target

    Roth Capital initiated coverage of BitFuFu with a rating of Buy and set a new price target of $6.00

    8/13/25 8:06:38 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    B. Riley Securities resumed coverage on Journey Medical with a new price target

    B. Riley Securities resumed coverage of Journey Medical with a rating of Buy and set a new price target of $12.00

    7/30/25 8:21:38 AM ET
    $DERM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    SEC Filings

    View All

    SEC Form 6-K filed by Immuron Limited

    6-K - Immuron Ltd (0001660046) (Filer)

    10/30/25 9:34:21 PM ET
    $IMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by U.S. Energy Corp.

    SCHEDULE 13D/A - US ENERGY CORP (0000101594) (Subject)

    10/30/25 6:17:17 PM ET
    $USEG
    Oil & Gas Production
    Energy

    SEC Form 10-Q filed by NCS Multistage Holdings Inc.

    10-Q - NCS Multistage Holdings, Inc. (0001692427) (Filer)

    10/30/25 4:10:31 PM ET
    $NCSM
    Oilfield Services/Equipment
    Energy

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Leadership Updates

    Live Leadership Updates

    View All

    Lilly to Acquire Adverum Biotechnologies

    Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose  Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gene therapy's potential to alleviate the burden of age-related diseases  INDIANAPOLIS and REDWOOD CITY, Calif., Oct. 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy with the aim of preserving sight for life in highly prevalent ocular diseases, today announced a definitive agreement for Lilly to acquire Adve

    10/24/25 8:30:00 AM ET
    $ADVM
    $LLY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

    ORLANDO, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (the "Company") is pleased to announce that it has been invited to present on the Emerging Growth Conference on August 20, 2025. The next Emerging Growth Conference is presenting on August 20, 2025. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's Chairman, Serguei Melnik in real time. Mr. Melnik will perform a presentation and may subsequently open the floor for questions. Please submit your questions in advance to [email protected] or ask your questions during the event and Mr. Melnik will do his best to

    8/18/25 9:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    22nd Century Announces First Shipments of Pinnacle VLN® Products to Top 5 C-Store Chain Locations Across 12 States

    Pinnacle VLN® from 22nd Century Gains 2nd Early Adopter to Join Popular Pinnacle Branded Conventional Cigarette Products Already Sold at Top-5 U.S. C-Store Chain MOCKSVILLE, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced the first shipments of its new Pinnacle VLN® Gold and Pinnacle VLN® Menthol reduced nicotine content cigarettes into distribution. These initial Pinnacle VLN® shipments will support a sales launch expected on September 1, 2025 at almost 1,000 locations across 12 states for a

    8/4/25 8:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Financials

    Live finance-specific insights

    View All

    Grove to Report Third Quarter 2025 Financial Results on November 13, 2025

    Grove Collaborative Holdings, Inc. (NYSE:GROV) ("Grove" or "the Company"), the world's first plastic-neutral retailer and a leading sustainable consumer products company, certified B Corporation, and Public Benefit Corporation today announced that it will report third quarter 2025 financial results after the market closes on Thursday, November 13, 2025. The Company will host an investor conference call and webcast to review these financial results at 5:00pm ET / 2:00pm PT on the same day. The webcast can be accessed at https://investors.grove.co/. The conference call can be accessed by calling 877-413-7205. International callers may dial +1 201-689-8537. A replay of the call will be avail

    10/30/25 4:10:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    NCS Multistage Holdings, Inc. Announces Third Quarter 2025 Results

    Third Quarter Results Total revenues of $46.5 million, a 6% year-over-year improvementNet income of $3.8 million and diluted earnings per share of $1.37, compared to net income of $4.1 million and diluted earnings per share of $1.60 in the same quarter of 2024Adjusted EBITDA of $7.0 million, consistent with the same quarter of 2024 $25.3 million in cash and $7.4 million of total debt as of September 30, 2025 HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (NASDAQ:NCSM) (the "Company," "NCS," "we" or "us"), a leading provider of highly engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completio

    10/29/25 4:05:00 PM ET
    $NCSM
    Oilfield Services/Equipment
    Energy

    NCS Multistage Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call

    HOUSTON, Oct. 22, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. ("NCS" or the "Company") (NASDAQ:NCSM) will host a conference call to discuss its third quarter 2025 results on Thursday, October 30, 2025 at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). NCS will issue its third quarter 2025 earnings release the evening prior to the conference call. The conference call will be available via a live audio webcast. Participants who wish to ask questions may register for the call here to receive the dial-in numbers and unique PIN. If you wish to join the conference call but do not plan to ask questions, you may join the listen-only webcast here. It is recommended that participants jo

    10/22/25 4:10:16 PM ET
    $NCSM
    Oilfield Services/Equipment
    Energy

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Journey Medical Corporation

    SC 13G - Journey Medical Corp (0001867066) (Subject)

    11/29/24 2:00:25 PM ET
    $DERM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:57:12 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care